Beacon Pointe Advisors, LLC Humacyte, Inc. Transaction History
Beacon Pointe Advisors, LLC
- $8.55 Billion
- Q3 2024
A detailed history of Beacon Pointe Advisors, LLC transactions in Humacyte, Inc. stock. As of the latest transaction made, Beacon Pointe Advisors, LLC holds 15,000 shares of HUMA stock, worth $67,650. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,000
Previous 10,000
50.0%
Holding current value
$67,650
Previous $48,000
68.75%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding HUMA
# of Institutions
150Shares Held
35.1MCall Options Held
279KPut Options Held
607K-
Black Rock Inc. New York, NY7.14MShares$32.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.06MShares$22.8 Million0.0% of portfolio
-
State Street Corp Boston, MA4.76MShares$21.5 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.04MShares$9.2 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.27MShares$5.72 Million0.0% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $465M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...